Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review.

West R, Shiffman S.

Psychopharmacology (Berl). 2001 May;155(2):115-22.

PMID:
11400998
2.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

3.

Nicotine replacement therapy.

Fant RV, Owen LL, Henningfield JE.

Prim Care. 1999 Sep;26(3):633-52. Review.

PMID:
10436291
4.

Glucose for smoking cessation: does it have a role?

West R.

CNS Drugs. 2001;15(4):261-5. Review.

PMID:
11463131
5.

Bupropion for the treatment of nicotine withdrawal and craving.

Mooney ME, Sofuoglu M.

Expert Rev Neurother. 2006 Jul;6(7):965-81. Review.

PMID:
16831112
6.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
7.

Psychology and pharmacology in cigarette withdrawal.

West RJ.

J Psychosom Res. 1984;28(5):379-86. Review.

PMID:
6392535
8.

Pharmacotherapy for tobacco dependence.

Fant RV, Buchhalter AR, Buchman AC, Henningfield JE.

Handb Exp Pharmacol. 2009;(192):487-510. doi: 10.1007/978-3-540-69248-5_17. Review.

PMID:
19184660
9.

Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.

Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE.

CNS Drugs. 2001;15(6):453-67. Review.

PMID:
11524024
10.

Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.

Shiffman S, West R, Gilbert D; SRNT Work Group on the Assessment of Craving and Withdrawal in Clinical Trials.

Nicotine Tob Res. 2004 Aug;6(4):599-614. Review.

PMID:
15370156
11.

Pharmacotherapy for smoking cessation.

Nunn-Thompson CL, Simon PA.

Clin Pharm. 1989 Oct;8(10):710-20. Review.

PMID:
2680239
12.

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

Foulds J.

Int J Clin Pract. 2006 May;60(5):571-6. Review.

PMID:
16700857
13.

Nicotine delivery systems.

Shiffman S, Fant RV, Buchhalter AR, Gitchell JG, Henningfield JE.

Expert Opin Drug Deliv. 2005 May;2(3):563-77. Review.

PMID:
16296775
14.

Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review.

Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT.

Nicotine Tob Res. 2006 Oct;8(5):627-38. Review.

PMID:
17008190
15.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
16.

Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.

Le Houezec J.

Int J Tuberc Lung Dis. 2003 Sep;7(9):811-9. Review.

PMID:
12971663
17.

Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Ray R, Schnoll RA, Lerman C.

CNS Drugs. 2007;21(7):525-33. Review.

PMID:
17579497
18.
19.

Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?

Sims TH, Fiore MC.

CNS Drugs. 2002;16(10):653-62. Review.

PMID:
12269859
20.

New medications for nicotine dependence treatment.

Hurt RD.

Nicotine Tob Res. 1999;1 Suppl 2:S175-9; discussion S207-10. Review.

PMID:
11768177

Supplemental Content

Support Center